Cargando…

Atrial fibrillation and 24‐h ambulatory blood pressure pattern

Detalles Bibliográficos
Autor principal:	Verberk, Willem J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Atrial Fibrillation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278569/ https://www.ncbi.nlm.nih.gov/pubmed/35702949 http://dx.doi.org/10.1111/jch.14522

Ejemplares similares

Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients
por: Coccina, Francesca, et al.
Publicado: (2020)

Prediction of atrial fibrillation in patients with hypertension: A comprehensive comparison of office and ambulatory blood pressure measurements
por: Huang, Pin‐Hsiang, et al.
Publicado: (2022)

Atrial fibrillation is associated with increased central blood pressure and arterial stiffness
por: Pauklin, Priit, et al.
Publicado: (2021)

Future Directions for Mapping Atrial Fibrillation
por: Zaman, Junaid AB, et al.
Publicado: (2022)

Atrial Fibrillation in Congenital Heart Disease
por: Martín de Miguel, Irene, et al.
Publicado: (2021)

Atrial fibrillation in cardiac resynchronization therapy
por: Elliott, Mark K., et al.
Publicado: (2021)

Neuromodulatory Approaches for Atrial Fibrillation Ablation
por: Rodríguez-Mañero, Moisés, et al.
Publicado: (2021)

Pulsed Field Ablation for Atrial Fibrillation
por: Schaack, David, et al.
Publicado: (2023)

Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation
por: Harmon, David M, et al.
Publicado: (2023)

Ablation as First-line Therapy for Atrial Fibrillation
por: Andrade, Jason G
Publicado: (2023)

Genetic risk and atrial fibrillation in patients with heart failure
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
por: Andrade, Jason G, et al.
Publicado: (2022)

Atrial fibrillation in heart failure: Prime time for ablation!
por: Deisenhofer, Isabel
Publicado: (2021)

Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies
por: Al-Kaisey, Ahmed M, et al.
Publicado: (2023)

Association Between Left Atrial Appendage Morphology and Function and the Risk of Ischaemic Stroke in Patients with Atrial Fibrillation
por: Dudziñska-Szczerba, Katarzyna, et al.
Publicado: (2022)

Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Clinical Relevance of Sinus Rhythm Mapping to Quantify Electropathology Related to Atrial Fibrillation
por: van Schie, Mathijs S, et al.
Publicado: (2022)

Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation
por: Rosa, Giulio La, et al.
Publicado: (2021)

Atrial fibrillation and heart failure: A contemporary review of current management approaches
por: Lee, Justin Z., et al.
Publicado: (2021)

A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
por: Kaba, Riyaz A, et al.
Publicado: (2022)

Management of Atrial Fibrillation Using Immunoglobulin Free Light Chains, Novel Biomarkers of Inflammation
por: Matsumori, Akira
Publicado: (2022)

Prevalence and prognosis of atrial fibrillation in a hypertensive population: A prospective cohort study
por: Wang, Chang, et al.
Publicado: (2023)

Prevalence of atrial fibrillation and the risk of cardiovascular mortality among hypertensive elderly population in northeast China
por: Xia, Zhenwei, et al.
Publicado: (2022)

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
por: Johner, Nicolas, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Ganglionic Plexus Ablation: A Step-by-step Guide for Electrophysiologists and Review of Modalities for Neuromodulation for the Management of Atrial Fibrillation
por: Aksu, Tolga, et al.
Publicado: (2023)

Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know
por: Merella, Pierluigi, et al.
Publicado: (2023)

‘Pill-in-the-pocket’ Oral Anticoagulation Guided by Daily Rhythm Monitoring for Stroke Prevention in Patients with AF: A Systematic Review and Meta-analysis
por: Briosa e Gala, Andre, et al.
Publicado: (2023)

PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
por: Syeda, Fahima, et al.
Publicado: (2017)

Systolic, diastolic blood pressure and pulse pressure and risk of stroke in young aged patients with atrial fibrillation
por: Lee, S R, et al.
Publicado: (2023)

Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients
por: Papakonstantinou, P, et al.
Publicado: (2023)

Global burden of atrial fibrillation/flutter due to high systolic blood pressure from 1990 to 2019: estimates from the global burden of disease study 2019
por: Jin, Yaqiong, et al.
Publicado: (2022)

Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer
por: Shabtaie, Samuel A., et al.
Publicado: (2023)

Incidence of atrial fibrillation in patients with central retinal artery occlusion: A Systematic Review and Meta-Analysis
por: Nedios, S, et al.
Publicado: (2023)

Atrial fibrillation and in-hospital mortality in Covid-19 patients
por: Kotadia, I, et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?
por: Luojus, A, et al.
Publicado: (2023)

How often atrial flutter and atrial fibrillation coexist? Results from a large nationwide ECG-based study
por: Aro, A, et al.
Publicado: (2023)

Disagreement of ESC guidelines from 2016 and 2021 and HFA-PEFF and H2 FPEF scores in diagnosis of heart failure with preserved ejection fraction in atrial fibrillation patients
por: Gawalko, M, et al.
Publicado: (2023)

Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials
por: Alexandre, Joachim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d9o3h0ljkgejs8n55shbr3culg